In silico CD4+ T-cell epitope prediction and HLA distribution analysis for the potential proteins of Neisseria meningitidis Serogroup B—A clue for vaccine development
Neisseria meningitidis, an exclusive human pathogen, is a major cause of mortality due to meningococcal meningitis and sepsis in many developing countries. Three meningococcal serogroup B proteins, i.e. T-cell stimulating protein A (TspA), autotransporter A (AutA), and IgA-specific serine endopeptid...
Saved in:
| Published in | Vaccine Vol. 28; no. 43; pp. 7092 - 7097 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Kidlington
Elsevier Ltd
08.10.2010
Elsevier Elsevier Limited |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0264-410X 1873-2518 1873-2518 |
| DOI | 10.1016/j.vaccine.2010.08.005 |
Cover
| Abstract | Neisseria meningitidis, an exclusive human pathogen, is a major cause of mortality due to meningococcal meningitis and sepsis in many developing countries. Three meningococcal serogroup B proteins, i.e. T-cell stimulating protein A (TspA), autotransporter A (AutA), and IgA-specific serine endopeptidase (IGA1) elicits CD4+ T-cell response and may enhance the effectiveness of meningococcal vaccines by acting as protective immunogens. A very limited data on T-helper cell epitopes in
MenB proteins is available. Hence,
in silico prediction of peptide sequences which may act as helper T lymphocyte epitopes in
MenB proteins was carried out by NetMHCIIpan web server. HLA distribution analysis was done by using the population coverage tool of Immune Epitope Database to determine the fraction of individuals in various populations expected to respond to a given set of predicted T-cell epitopes based on HLA genotype frequencies. Six epitopic core sequences, two from each
MenB proteins, i.e. AutA, TspA and IgA1 protease were predicted to associate with a large number of HLA-DR alleles. These six peptides may act as T-cell epitope in more than 95% of populations in 8 out of 12 populations considered. The T-cell stimulation potential of these predicted peptides containing the core epitopic sequences is to be validated by using laboratory experiments for their efficient use as peptide vaccine candidates against
N. meningitidis serogroup B. |
|---|---|
| AbstractList | Neisseria meningitidis, an exclusive human pathogen, is a major cause of mortality due to meningococcal meningitis and sepsis in many developing countries. Three meningococcal serogroup B proteins, i.e. T-cell stimulating protein A (TspA), autotransporter A (AutA), and IgA-specific serine endopeptidase (IGA1) elicits CD4+ T-cell response and may enhance the effectiveness of meningococcal vaccines by acting as protective immunogens. A very limited data on T-helper cell epitopes in MenB proteins is available. Hence, in silico prediction of peptide sequences which may act as helper T lymphocyte epitopes in MenB proteins was carried out by NetMHCIIpan web server. HLA distribution analysis was done by using the population coverage tool of Immune Epitope Database to determine the fraction of individuals in various populations expected to respond to a given set of predicted T-cell epitopes based on HLA genotype frequencies. Six epitopic core sequences, two from each MenB proteins, i.e. AutA, TspA and IgA1 protease were predicted to associate with a large number of HLA-DR alleles. These six peptides may act as T-cell epitope in more than 95% of populations in 8 out of 12 populations considered. The T-cell stimulation potential of these predicted peptides containing the core epitopic sequences is to be validated by using laboratory experiments for their efficient use as peptide vaccine candidates against N. meningitidis serogroup B. Neisseria meningitidis, an exclusive human pathogen, is a major cause of mortality due to meningococcal meningitis and sepsis in many developing countries. Three meningococcal serogroup B proteins, i.e. T-cell stimulating protein A (TspA), autotransporter A (AutA), and IgA-specific serine endopeptidase (IGA1) elicits CD4+ T-cell response and may enhance the effectiveness of meningococcal vaccines by acting as protective immunogens. A very limited data on T-helper cell epitopes inMenBproteins is available. Hence,in silicoprediction of peptide sequences which may act as helper T lymphocyte epitopes inMenBproteins was carried out by NetMHCIIpan web server. HLA distribution analysis was done by using the population coverage tool of Immune Epitope Database to determine the fraction of individuals in various populations expected to respond to a given set of predicted T-cell epitopes based on HLA genotype frequencies. Six epitopic core sequences, two from eachMenBproteins, i.e. AutA, TspA and IgA1 protease were predicted to associate with a large number of HLA-DR alleles. These six peptides may act as T-cell epitope in more than 95% of populations in 8 out of 12 populations considered. The T-cell stimulation potential of these predicted peptides containing the core epitopic sequences is to be validated by using laboratory experiments for their efficient use as peptide vaccine candidates againstN. meningitidisserogroup B. Abstract Neisseria meningitidis , an exclusive human pathogen, is a major cause of mortality due to meningococcal meningitis and sepsis in many developing countries. Three meningococcal serogroup B proteins, i.e. T-cell stimulating protein A (TspA), autotransporter A (AutA), and IgA-specific serine endopeptidase (IGA1) elicits CD4+ T-cell response and may enhance the effectiveness of meningococcal vaccines by acting as protective immunogens. A very limited data on T-helper cell epitopes in MenB proteins is available. Hence, in silico prediction of peptide sequences which may act as helper T lymphocyte epitopes in MenB proteins was carried out by NetMHCIIpan web server. HLA distribution analysis was done by using the population coverage tool of Immune Epitope Database to determine the fraction of individuals in various populations expected to respond to a given set of predicted T-cell epitopes based on HLA genotype frequencies. Six epitopic core sequences, two from each MenB proteins, i.e. AutA, TspA and IgA1 protease were predicted to associate with a large number of HLA-DR alleles. These six peptides may act as T-cell epitope in more than 95% of populations in 8 out of 12 populations considered. The T-cell stimulation potential of these predicted peptides containing the core epitopic sequences is to be validated by using laboratory experiments for their efficient use as peptide vaccine candidates against N. meningitidis serogroup B. Neisseria meningitidis, an exclusive human pathogen, is a major cause of mortality due to meningococcal meningitis and sepsis in many developing countries. Three meningococcal serogroup B proteins, i.e. T-cell stimulating protein A (TspA), autotransporter A (AutA), and IgA-specific serine endopeptidase (IGA1) elicits CD4+ T-cell response and may enhance the effectiveness of meningococcal vaccines by acting as protective immunogens. A very limited data on T-helper cell epitopes in MenB proteins is available. Hence, in silico prediction of peptide sequences which may act as helper T lymphocyte epitopes in MenB proteins was carried out by NetMHCIIpan web server. HLA distribution analysis was done by using the population coverage tool of Immune Epitope Database to determine the fraction of individuals in various populations expected to respond to a given set of predicted T-cell epitopes based on HLA genotype frequencies. Six epitopic core sequences, two from each MenB proteins, i.e. AutA, TspA and IgA1 protease were predicted to associate with a large number of HLA-DR alleles. These six peptides may act as T-cell epitope in more than 95% of populations in 8 out of 12 populations considered. The T-cell stimulation potential of these predicted peptides containing the core epitopic sequences is to be validated by using laboratory experiments for their efficient use as peptide vaccine candidates against N. meningitidis serogroup B.Neisseria meningitidis, an exclusive human pathogen, is a major cause of mortality due to meningococcal meningitis and sepsis in many developing countries. Three meningococcal serogroup B proteins, i.e. T-cell stimulating protein A (TspA), autotransporter A (AutA), and IgA-specific serine endopeptidase (IGA1) elicits CD4+ T-cell response and may enhance the effectiveness of meningococcal vaccines by acting as protective immunogens. A very limited data on T-helper cell epitopes in MenB proteins is available. Hence, in silico prediction of peptide sequences which may act as helper T lymphocyte epitopes in MenB proteins was carried out by NetMHCIIpan web server. HLA distribution analysis was done by using the population coverage tool of Immune Epitope Database to determine the fraction of individuals in various populations expected to respond to a given set of predicted T-cell epitopes based on HLA genotype frequencies. Six epitopic core sequences, two from each MenB proteins, i.e. AutA, TspA and IgA1 protease were predicted to associate with a large number of HLA-DR alleles. These six peptides may act as T-cell epitope in more than 95% of populations in 8 out of 12 populations considered. The T-cell stimulation potential of these predicted peptides containing the core epitopic sequences is to be validated by using laboratory experiments for their efficient use as peptide vaccine candidates against N. meningitidis serogroup B. Neisseria meningitidis, an exclusive human pathogen, is a major cause of mortality due to meningococcal meningitis and sepsis in many developing countries. Three meningococcal serogroup B proteins, i.e. T-cell stimulating protein A (TspA), autotransporter A (AutA), and IgA-specific serine endopeptidase (IGA1) elicits CD4+ T-cell response and may enhance the effectiveness of meningococcal vaccines by acting as protective immunogens. A very limited data on T-helper cell epitopes in MenB proteins is available. Hence, in silico prediction of peptide sequences which may act as helper T lymphocyte epitopes in MenB proteins was carried out by NetMHCIIpan web server. HLA distribution analysis was done by using the population coverage tool of Immune Epitope Database to determine the fraction of individuals in various populations expected to respond to a given set of predicted T-cell epitopes based on HLA genotype frequencies. Six epitopic core sequences, two from each MenB proteins, i.e. AutA, TspA and IgA1 protease were predicted to associate with a large number of HLA-DR alleles. These six peptides may act as T-cell epitope in more than 95% of populations in 8 out of 12 populations considered. The T-cell stimulation potential of these predicted peptides containing the core epitopic sequences is to be validated by using laboratory experiments for their efficient use as peptide vaccine candidates against N. meningitidis serogroup B. , an exclusive human pathogen, is a major cause of mortality due to meningococcal meningitis and sepsis in many developing countries. Three meningococcal serogroup B proteins, i.e. T-cell stimulating protein A (TspA), autotransporter A (AutA), and IgA-specific serine endopeptidase (IGA1) elicits CD4+ T-cell response and may enhance the effectiveness of meningococcal vaccines by acting as protective immunogens. A very limited data on T-helper cell epitopes in proteins is available. Hence, prediction of peptide sequences which may act as helper T lymphocyte epitopes in proteins was carried out by NetMHCIIpan web server. HLA distribution analysis was done by using the population coverage tool of Immune Epitope Database to determine the fraction of individuals in various populations expected to respond to a given set of predicted T-cell epitopes based on HLA genotype frequencies. Six epitopic core sequences, two from each proteins, i.e. AutA, TspA and IgA1 protease were predicted to associate with a large number of HLA-DR alleles. These six peptides may act as T-cell epitope in more than 95% of populations in 8 out of 12 populations considered. The T-cell stimulation potential of these predicted peptides containing the core epitopic sequences is to be validated by using laboratory experiments for their efficient use as peptide vaccine candidates against serogroup B. |
| Author | Smita, Suchi Akhoon, Bashir A. Gupta, Shishir K. Srivastava, Mugdha Sarangi, Aditya Narayan Rahman, Qamar Gupta, Shailendra K. |
| Author_xml | – sequence: 1 givenname: Shishir K. surname: Gupta fullname: Gupta, Shishir K. organization: Society for Biological Research & Rural Development, Lucknow, UP, India – sequence: 2 givenname: Suchi surname: Smita fullname: Smita, Suchi organization: Department of Bioinformatics, Integral University, Lucknow, UP, India – sequence: 3 givenname: Aditya Narayan surname: Sarangi fullname: Sarangi, Aditya Narayan organization: Biomedical Informatics Centre, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226014, India – sequence: 4 givenname: Mugdha surname: Srivastava fullname: Srivastava, Mugdha organization: Society for Biological Research & Rural Development, Lucknow, UP, India – sequence: 5 givenname: Bashir A. surname: Akhoon fullname: Akhoon, Bashir A. organization: Centre of Bioinformatics, Department of Biotechnology, SMVD University, Jammu, India – sequence: 6 givenname: Qamar surname: Rahman fullname: Rahman, Qamar organization: Department of Bioinformatics, Integral University, Lucknow, UP, India – sequence: 7 givenname: Shailendra K. surname: Gupta fullname: Gupta, Shailendra K. email: skgupta@iitr.res.in organization: Indian Institute of Toxicology Research (CSIR), P.O. Box 80, MG Marg, Lucknow 226001, India |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23341470$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/20716448$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNku2K1DAUhousuLOjl6AERBSkY9KmH4OojOPHLgz6Y1fYfyFNT9cz20lqki7MPy_Ci_C6vBJTp7owoCsEGk6f9yXnnPcoOtBGQxTdZ3TGKMufrWdXUinUMEtoqNFyRml2K5qwskjjJGPlQTShSc5jzuj5YXTk3JoGImXzO9FhQguWc15Oou8nmjhsURmyfMOfkrNYQdsS6NCbDkhnoUbl0WgidU2OVwtSo_MWq34synbr0JHGWOI_B4HxoD3KNkjDFbUjpiEfAJ0Di5JsQKO-QI_BhpyCNRfW9B15_ePrtwVRbQ-_nMbWSA1X0JouiPzd6HYjWwf3xu80-vTu7dnyOF59fH-yXKxileXcx5Viw8kUrWhCkzLPsjwJTRcMZDNPc1WosqkrJcuUAzRhQDwUG1rxnIbfWTqNHu98w_u_9OC82KAbZiI1mN6JIit4nhYlC-STf5Iso7QokmAb0Id76Nr0NswuUHxeJEme52WgHoxUX22gFp3FjbRb8XtbAXg0AtIp2TZWaoXumktTznhBA5ftOGWNcxaaPwijYkiPWItxxGJIj6ClGLIxjZ7v6RR6OSzaW4ntjepXOzWE9VwhWOEUglYhQRaUF7XBGx1e7jmoFjWGVi9hC-56ZsIlgorTId9DvBmljDF-Hgxe_N3gPx7wE9gDDoE |
| CODEN | VACCDE |
| CitedBy_id | crossref_primary_10_3390_vaccines12121355 crossref_primary_10_1016_j_vaccine_2012_10_091 crossref_primary_10_1016_j_jksus_2021_101751 crossref_primary_10_1016_j_meegid_2012_03_023 crossref_primary_10_1080_21645515_2017_1356961 crossref_primary_10_1016_j_meegid_2010_10_013 crossref_primary_10_1007_s10989_018_9764_z crossref_primary_10_1186_s12865_015_0119_7 crossref_primary_10_1007_s12010_014_1245_z crossref_primary_10_1007_s11033_018_4505_0 crossref_primary_10_1016_j_jtbi_2015_08_003 crossref_primary_10_1093_bib_bbv046 crossref_primary_10_1186_1471_2164_14_S6_S4 crossref_primary_10_1016_j_micpath_2011_01_011 crossref_primary_10_1099_mic_0_071829_0 crossref_primary_10_1155_2015_189153 crossref_primary_10_1007_s13205_015_0352_z crossref_primary_10_1134_S1068162018010193 crossref_primary_10_1007_s13721_016_0142_5 crossref_primary_10_1134_S106816202104021X crossref_primary_10_1021_pr200806s crossref_primary_10_1371_journal_pone_0149638 crossref_primary_10_1007_s10989_015_9461_0 crossref_primary_10_1093_femspd_ftv026 crossref_primary_10_1158_2326_6066_CIR_16_0240_T crossref_primary_10_1007_s00726_010_0830_x crossref_primary_10_1016_j_meegid_2012_02_022 crossref_primary_10_1016_j_meegid_2021_104795 crossref_primary_10_3389_fmed_2022_1008527 crossref_primary_10_1007_s10517_018_4260_1 |
| Cites_doi | 10.1016/S0959-440X(99)00039-1 10.1016/S1359-6446(05)03720-7 10.1128/CMR.2.Suppl.S134 10.1111/j.1399-0039.2008.01083.x 10.1016/j.vaccine.2006.09.032 10.1016/0091-6749(91)92157-V 10.1136/jcp.56.6.417 10.1128/MMBR.57.1.34-49.1993 10.1517/14622416.5.4.417 10.1016/S0022-2836(03)00750-2 10.1016/0264-410X(95)00101-6 10.1016/j.ymeth.2004.06.007 10.1016/j.clim.2008.12.003 10.1016/0264-410X(92)90005-5 10.1016/j.vaccine.2005.01.059 10.1016/S0969-2126(00)00026-5 10.1002/psc.896 10.1586/14760584.4.3.407 10.1517/14622416.5.6.597 10.1007/s002510050594 10.1016/0882-4010(87)90059-3 10.1046/j.1365-2958.2000.02061.x 10.1016/S0167-7012(01)00290-1 10.1016/j.vaccine.2006.03.013 10.1172/JCI109383 10.1016/S0264-410X(01)00283-3 10.1016/0140-6736(91)91961-S 10.1371/journal.pcbi.1000107 10.1093/nar/gkp1004 10.1016/j.it.2003.10.006 10.1016/j.vaccine.2003.10.027 10.1093/infdis/167.5.1065 10.1136/adc.2006.111500 10.1006/mpat.1993.1070 10.1016/j.vaccine.2006.12.023 10.1016/j.vaccine.2004.08.046 10.1007/s002510050595 10.1086/315158 10.1128/IAI.67.7.3533-3541.1999 10.4049/jimmunol.138.12.4402 10.1046/j.1440-1711.2002.01092.x 10.1093/infdis/126.5.514 10.1016/j.vaccine.2007.08.044 10.1186/1471-2105-9-S12-S22 10.1016/j.drudis.2007.03.010 10.1016/S0891-5520(05)70273-7 10.1016/j.vaccine.2006.06.019 10.1016/S0264-410X(02)00407-3 10.1186/1471-2105-7-153 10.1016/j.vaccine.2005.08.111 10.1016/j.vaccine.2009.09.095 10.1186/1756-0500-2-61 10.1016/S0140-6736(83)90340-9 10.1128/IAI.70.1.335-344.2002 |
| ContentType | Journal Article |
| Copyright | 2010 Elsevier Ltd Elsevier Ltd 2015 INIST-CNRS Copyright © 2010 Elsevier Ltd. All rights reserved. Copyright Elsevier Limited Oct 8, 2010 |
| Copyright_xml | – notice: 2010 Elsevier Ltd – notice: Elsevier Ltd – notice: 2015 INIST-CNRS – notice: Copyright © 2010 Elsevier Ltd. All rights reserved. – notice: Copyright Elsevier Limited Oct 8, 2010 |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7QL 7RV 7T2 7T5 7U9 7X7 7XB 88C 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9- K9. KB0 LK8 M0R M0S M0T M1P M2O M7N M7P MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 |
| DOI | 10.1016/j.vaccine.2010.08.005 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Nursing & Allied Health Database Health and Safety Science Abstracts (Full archive) Immunology Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database ProQuest SciTech Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library AIDS and Cancer Research Abstracts SciTech Premium Collection Consumer Health Database (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences Consumer Health Database Health & Medical Collection (Alumni) Healthcare Administration Database Medical Database Research Library Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Research Library (Corporate) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student ProQuest Central Essentials SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Research Library Health & Safety Science Abstracts ProQuest Public Health ProQuest Central Basic ProQuest Health Management ProQuest Nursing & Allied Health Source ProQuest SciTech Collection ProQuest Medical Library Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Research Library Prep MEDLINE - Academic AIDS and Cancer Research Abstracts |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Veterinary Medicine Biology Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1873-2518 |
| EndPage | 7097 |
| ExternalDocumentID | 3216315331 20716448 23341470 10_1016_j_vaccine_2010_08_005 S0264410X1001114X 1_s2_0_S0264410X1001114X |
| Genre | Journal Article |
| GroupedDBID | --- --K --M .1- .FO .GJ .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 29Q 4.4 457 4G. 53G 5RE 5VS 7-5 71M 7RV 7X7 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8P~ 9JM AAAJQ AABNK AAEDT AAEDW AAHBH AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABFRF ABJNI ABKYH ABMAC ABMZM ABRWV ABUWG ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACIUM ACLOT ACMHX ACPRK ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADFRT ADMUD ADNMO ADSLC ADVLN AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEUYN AEVXI AEXOQ AFJKZ AFKRA AFPUW AFRAH AFRHN AFTJW AFXIZ AGEKW AGGSO AGHFR AGQPQ AGUBO AGWPP AGYEJ AHHHB AHMBA AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP AQUVI ASPBG AVWKF AXJTR AZFZN AZQEC BBNVY BENPR BHPHI BKEYQ BKNYI BKOJK BLXMC BNPGV BPHCQ BVXVI CCPQU CJTIS CNWQP CS3 DWQXO EBS EFJIC EFKBS EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN FYUFA G-2 G-Q GBLVA GNUQQ GUQSH HCIFZ HEJ HLV HMCUK HMG HMK HMO HVGLF HX~ HZ~ IHE J1W K9- KOM L7B LK8 LUGTX LW9 M0R M0T M1P M29 M2O M41 M7P MO0 N9A NAPCQ O-L O9- O9~ OAUVE OK0 OZT P-8 P-9 P2P PC. PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO Q38 R2- ROL RPZ SAB SAE SCC SDF SDG SDP SES SEW SIN SNL SPCBC SSH SSI SSZ SVS T5K UKHRP UV1 WH7 WOW WUQ XPP Z5R ZGI ZXP ~G- ~HD 3V. AACTN AFCTW AFKWA AJOXV ALIPV AMFUW RIG AAIAV ABLVK ABYKQ AESVU AJBFU LCYCR QYZTP AAYXX CITATION PUEGO AGCQF AGRNS IQODW CGR CUY CVF ECM EIF NPM 7QL 7T2 7T5 7U9 7XB 8FK AFFHD C1K H94 K9. M7N MBDVC PKEHL PQEST PQUKI PRINS Q9U 7X8 |
| ID | FETCH-LOGICAL-c564t-bc1bc1b5c0b020286556231971eaf936c7c8fdbca834eef264436cf0b46093653 |
| IEDL.DBID | BENPR |
| ISSN | 0264-410X 1873-2518 |
| IngestDate | Thu Oct 02 11:49:54 EDT 2025 Tue Oct 07 08:17:13 EDT 2025 Tue Oct 28 03:39:29 EDT 2025 Thu Apr 03 07:00:01 EDT 2025 Mon Jul 21 09:17:25 EDT 2025 Thu Apr 24 23:00:52 EDT 2025 Wed Oct 01 04:17:29 EDT 2025 Fri Feb 23 02:28:41 EST 2024 Sun Feb 23 10:19:56 EST 2025 Tue Oct 14 19:35:58 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 43 |
| Keywords | MHC polymorphism OMP Population coverage T-cell epitope MenB IEDB MHC Neisseria meningitidis Vaccine HLA Neisseria meningitidis Serogroup B major histocompatibility complex outer membrane protein human leucocyte antigen Immune Epitope Database HLA-System CD4 T lymphocyte Antigenic determinant Major histocompatibility system Neisseriaceae Protein T-Lymphocyte Bacteria Micrococcales Polymorphism |
| Language | English |
| License | https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0 Copyright © 2010 Elsevier Ltd. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c564t-bc1bc1b5c0b020286556231971eaf936c7c8fdbca834eef264436cf0b46093653 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
| PMID | 20716448 |
| PQID | 1497226668 |
| PQPubID | 105530 |
| PageCount | 6 |
| ParticipantIDs | proquest_miscellaneous_757463781 proquest_miscellaneous_1500772093 proquest_journals_1497226668 pubmed_primary_20716448 pascalfrancis_primary_23341470 crossref_primary_10_1016_j_vaccine_2010_08_005 crossref_citationtrail_10_1016_j_vaccine_2010_08_005 elsevier_sciencedirect_doi_10_1016_j_vaccine_2010_08_005 elsevier_clinicalkeyesjournals_1_s2_0_S0264410X1001114X elsevier_clinicalkey_doi_10_1016_j_vaccine_2010_08_005 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2010-10-08 |
| PublicationDateYYYYMMDD | 2010-10-08 |
| PublicationDate_xml | – month: 10 year: 2010 text: 2010-10-08 day: 08 |
| PublicationDecade | 2010 |
| PublicationPlace | Kidlington |
| PublicationPlace_xml | – name: Kidlington – name: Netherlands |
| PublicationTitle | Vaccine |
| PublicationTitleAlternate | Vaccine |
| PublicationYear | 2010 |
| Publisher | Elsevier Ltd Elsevier Elsevier Limited |
| Publisher_xml | – name: Elsevier Ltd – name: Elsevier – name: Elsevier Limited |
| References | Ait-Tahar, Wooldridge, Turner, Atta, Todd, Ala’Aldeen (bib0095) 2000; 37 The immune epitope database 2.0. Nucleic Acids Res 2010;38(Database issue):D854–62. Gupta, Singh, Srivastava, Gupta, Akhoon (bib0185) 2009; 28 Zollinger, Mandrell, Griffiss, Altieri, Berman (bib0040) 1979; 63 Bui, Sidney, Dinh, Southwood, Newman, Sette (bib0150) 2006; 7 Agrawal, Srivastava, Borkar, Chaudhuri (bib0155) 2008; 72 Pace, Pollard (bib0010) 2007; 92 Lifely, Rogers, Esdaile, Payne, John (bib0135) 1992; 10 Davies, Flower (bib0245) 2007; 12 Brusic, August, Petrovsky (bib0180) 2005; 4 Wiwanitkit (bib0270) 2007; 25 A database of MHC/TAP binding peptides and T-cell epitopes. BMC Res Notes 2009;2:61. Gregory, Lesinski, Julie (bib0105) 2001; 47 Brusic, August (bib0210) 2004; 5 Rammensee, Bachmann, Emmerich, Bachor, Stevanovic (bib0170) 1999; 50 De Groot, McMurry, Marcon, Franco, Rivera, Kutzler (bib0255) 2005; 23 Poolman, Berthet (bib0065) 2001; 20 Kvalsvig, Unsworth (bib0020) 2003; 56 Azizi, Diaz-Mitoma (bib0225) 2008; 13 Rosenstein, Perkins, Stephens, Lefkowitz, Cartter, Danila (bib0005) 1999; 180 Saukkonen, Abdillahi, Poolman, Leinonen (bib0070) 1987; 3 Tsirpouchtsidis, Hurwitz, Brinkmann, Meyer, Haas (bib0100) 2002; 70 Lin, Zhang, Tongchusak, Reinherz, Brusic (bib0280) 2008; 9 Chaitra, Hariharaputran, Chandra, Shaila, Nayak (bib0260) 2005; 23 Amir-Kroll, Riveron, Sarmiento, Sierra, Acosta, Cohen (bib0130) 2006; 24 Stern, Wiley (bib0205) 1994; 2 Reche, Reinherz (bib0195) 2003; 331 Doytchinova, Flower (bib0275) 2007; 25 Parida, Shaila, Mukherjee, Chandra, Nayak (bib0265) 2007; 25 Doytchinova, Guan, Flower (bib0240) 2004; 34 Wyle, Artenstein, Brandt, Tramont, Kasper, Altieri (bib0035) 1972; 126 Flower (bib0235) 2003; 24 De Groot, Sbai, Aubin, McMurry, Martin (bib0230) 2002; 80 Howe, Dillon, Rogers, McCarter, Kelly, Gonzalez (bib0110) 2009; 131 Kizil, Todd, Atta, Borriello, Ait-Tahar, Ala’Aldeen (bib0090) 1999; 67 Rosenstein, Fischer, Tappero (bib0085) 2001; 15 Raziuddin, el-Awad, Mir (bib0115) 1991; 87 Esser, Marchese, Kierstead, Tussey, Wang, Chirmule (bib0190) 2003; 21 Vaughan, Skipp, O’Connor, Hudson, Vipond, Elmore (bib0120) 2006; 24 Bjune, Hoiby, Gronnesby, Arnesen, Fredriksen, Halstensen (bib0055) 1991; 338 De Groot (bib0175) 2006; 11 Finne, Bitter-Suermann, Goridis, Finne (bib0030) 1987; 138 Finne, Leinonen, Makela (bib0050) 1983; 322 Ovsyannikova, Jacobson, Poland (bib0215) 2004; 5 Verheul, Snippe, Poolman (bib0060) 1993; 57 Mesa, de León, Fernández (bib0125) 2006; 24 Rosenqvist, Hoiby, Wedege, Caugant, Froholm, McGuinness (bib0075) 1993; 15 Frasch (bib0015) 1989; 2 Sette, Sidney (bib0220) 1999; 50 Rosenqvist, Hoiby, Wedege, Kusecek, Achtman (bib0080) 1993; 167 Chabot, Goetghebeur, Grégoire (bib0250) 2004; 22 Idanpaan-Heikkila, Muttilainen, Wahlstrdm, Saarinen, Leinonen, Sarvas (bib0025) 1995; 13 Maenaka, Jones (bib0200) 2009; 9 Frasch (bib0045) 1989; 2 Nielsen, Lundegaard, Blicher, Peters, Sette (bib0140) 2008; 4 Raziuddin (10.1016/j.vaccine.2010.08.005_bib0115) 1991; 87 Rammensee (10.1016/j.vaccine.2010.08.005_bib0170) 1999; 50 Zollinger (10.1016/j.vaccine.2010.08.005_bib0040) 1979; 63 Poolman (10.1016/j.vaccine.2010.08.005_bib0065) 2001; 20 Tsirpouchtsidis (10.1016/j.vaccine.2010.08.005_bib0100) 2002; 70 Rosenstein (10.1016/j.vaccine.2010.08.005_bib0085) 2001; 15 Lifely (10.1016/j.vaccine.2010.08.005_bib0135) 1992; 10 Flower (10.1016/j.vaccine.2010.08.005_bib0235) 2003; 24 Lin (10.1016/j.vaccine.2010.08.005_bib0280) 2008; 9 Bjune (10.1016/j.vaccine.2010.08.005_bib0055) 1991; 338 Brusic (10.1016/j.vaccine.2010.08.005_bib0180) 2005; 4 Frasch (10.1016/j.vaccine.2010.08.005_bib0015) 1989; 2 De Groot (10.1016/j.vaccine.2010.08.005_bib0175) 2006; 11 Kvalsvig (10.1016/j.vaccine.2010.08.005_bib0020) 2003; 56 Frasch (10.1016/j.vaccine.2010.08.005_bib0045) 1989; 2 Amir-Kroll (10.1016/j.vaccine.2010.08.005_bib0130) 2006; 24 Stern (10.1016/j.vaccine.2010.08.005_bib0205) 1994; 2 Finne (10.1016/j.vaccine.2010.08.005_bib0030) 1987; 138 Idanpaan-Heikkila (10.1016/j.vaccine.2010.08.005_bib0025) 1995; 13 De Groot (10.1016/j.vaccine.2010.08.005_bib0255) 2005; 23 Azizi (10.1016/j.vaccine.2010.08.005_bib0225) 2008; 13 Rosenstein (10.1016/j.vaccine.2010.08.005_bib0005) 1999; 180 Doytchinova (10.1016/j.vaccine.2010.08.005_bib0240) 2004; 34 Rosenqvist (10.1016/j.vaccine.2010.08.005_bib0075) 1993; 15 Gregory (10.1016/j.vaccine.2010.08.005_bib0105) 2001; 47 Doytchinova (10.1016/j.vaccine.2010.08.005_bib0275) 2007; 25 10.1016/j.vaccine.2010.08.005_bib0160 Brusic (10.1016/j.vaccine.2010.08.005_bib0210) 2004; 5 Wiwanitkit (10.1016/j.vaccine.2010.08.005_bib0270) 2007; 25 Wyle (10.1016/j.vaccine.2010.08.005_bib0035) 1972; 126 Chabot (10.1016/j.vaccine.2010.08.005_bib0250) 2004; 22 Saukkonen (10.1016/j.vaccine.2010.08.005_bib0070) 1987; 3 Rosenqvist (10.1016/j.vaccine.2010.08.005_bib0080) 1993; 167 Sette (10.1016/j.vaccine.2010.08.005_bib0220) 1999; 50 Chaitra (10.1016/j.vaccine.2010.08.005_bib0260) 2005; 23 Mesa (10.1016/j.vaccine.2010.08.005_bib0125) 2006; 24 Maenaka (10.1016/j.vaccine.2010.08.005_bib0200) 2009; 9 Parida (10.1016/j.vaccine.2010.08.005_bib0265) 2007; 25 Reche (10.1016/j.vaccine.2010.08.005_bib0195) 2003; 331 Nielsen (10.1016/j.vaccine.2010.08.005_bib0140) 2008; 4 Ovsyannikova (10.1016/j.vaccine.2010.08.005_bib0215) 2004; 5 Verheul (10.1016/j.vaccine.2010.08.005_bib0060) 1993; 57 Finne (10.1016/j.vaccine.2010.08.005_bib0050) 1983; 322 De Groot (10.1016/j.vaccine.2010.08.005_bib0230) 2002; 80 Bui (10.1016/j.vaccine.2010.08.005_bib0150) 2006; 7 Howe (10.1016/j.vaccine.2010.08.005_bib0110) 2009; 131 Kizil (10.1016/j.vaccine.2010.08.005_bib0090) 1999; 67 Vaughan (10.1016/j.vaccine.2010.08.005_bib0120) 2006; 24 Esser (10.1016/j.vaccine.2010.08.005_bib0190) 2003; 21 Davies (10.1016/j.vaccine.2010.08.005_bib0245) 2007; 12 Pace (10.1016/j.vaccine.2010.08.005_bib0010) 2007; 92 Agrawal (10.1016/j.vaccine.2010.08.005_bib0155) 2008; 72 10.1016/j.vaccine.2010.08.005_bib0165 Gupta (10.1016/j.vaccine.2010.08.005_bib0185) 2009; 28 Ait-Tahar (10.1016/j.vaccine.2010.08.005_bib0095) 2000; 37 |
| References_xml | – volume: 20 start-page: S24 year: 2001 end-page: S26 ident: bib0065 article-title: Alternative vaccine strategies to prevent serogroup B meningococcal diseases publication-title: Vaccine – volume: 50 start-page: 201 year: 1999 end-page: 212 ident: bib0220 article-title: Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism publication-title: Immunogenetics – volume: 5 start-page: 417 year: 2004 end-page: 427 ident: bib0215 article-title: Variation in vaccine response in normal populations publication-title: Pharmacogenomics – volume: 24 start-page: 2692 year: 2006 end-page: 2699 ident: bib0125 article-title: Very small size proteoliposomes derived from publication-title: Vaccine – volume: 70 start-page: 335 year: 2002 end-page: 344 ident: bib0100 article-title: Neisserial Immunoglobulin A1 protease induces specific T-cell responses in humans publication-title: Infect Immun – volume: 131 start-page: 317 year: 2009 end-page: 332 ident: bib0110 article-title: Evidence for dendritic cell-dependent CD4+ T helper-1 type responses to commensal bacteria in normal human intestinal laminapropria publication-title: Clin Immunol – volume: 22 start-page: 1992 year: 2004 end-page: 2005 ident: bib0250 article-title: The societal value of universal childhood vaccination publication-title: Vaccine – volume: 5 start-page: 597 year: 2004 end-page: 600 ident: bib0210 article-title: The changing field of vaccine development in the genomics era publication-title: Pharmacogenomics – volume: 13 start-page: 1501 year: 1995 end-page: 1508 ident: bib0025 article-title: The antibody response to a prototype liposome vaccine containing Neisseria meningitides outer membrane protein P1 produced in publication-title: Vaccine – volume: 25 start-page: 7530 year: 2007 end-page: 7539 ident: bib0265 article-title: Computational analysis of proteome of H5N1 avian influenza virus to define T cell epitopes with vaccine potential publication-title: Vaccine – volume: 57 start-page: 34 year: 1993 end-page: 49 ident: bib0060 article-title: Meningococcal lipopolysaccharides: virulence factor and potential vaccine component publication-title: Microbiol Rev – volume: 37 start-page: 1094 year: 2000 end-page: 1105 ident: bib0095 article-title: Auto-transporter A (AutA) protein of publication-title: Mol Microbiol – volume: 25 start-page: 2768 year: 2007 end-page: 2770 ident: bib0270 article-title: Predicted epitopes of Lig A of publication-title: Vaccine – volume: 25 start-page: 856 year: 2007 end-page: 866 ident: bib0275 article-title: Identifying candidate subunit vaccines using an alignment-independent method based on principal amino acid properties publication-title: Vaccine – volume: 67 start-page: 3533 year: 1999 end-page: 3541 ident: bib0090 article-title: Identification and characterization of TspA, a major CD4+ T-cell- and B-cell-stimulating Neisseria-specific antigen publication-title: Infect Immun – volume: 11 start-page: 203 year: 2006 end-page: 209 ident: bib0175 article-title: Immunomics: discovering new targets for vaccines and therapeutics publication-title: Drug Discov Today – volume: 9 start-page: 745 year: 2009 end-page: 753 ident: bib0200 article-title: MHC superfamily structure and the immune system publication-title: Curr Opin Struct Biol – volume: 12 start-page: 389 year: 2007 end-page: 395 ident: bib0245 article-title: Harnessing bioinformatics to discover new vaccines publication-title: Drug Discov Today – volume: 28 start-page: 120 year: 2009 end-page: 131 ident: bib0185 article-title: In silico DNA vaccine designing against human papillomavirus (HPV) causing cervical cancer publication-title: Vaccine – volume: 2 start-page: S134 year: 1989 end-page: S138 ident: bib0015 article-title: Vaccines for prevention of meningococcal disease publication-title: Clin Microbiol Rev – volume: 34 start-page: 444 year: 2004 end-page: 453 ident: bib0240 article-title: Quantitative structure-activity relationships and the prediction of MHC supermotifs publication-title: Methods – volume: 80 start-page: 255 year: 2002 end-page: 269 ident: bib0230 article-title: Immuno-informatics: mining genomes for vaccine components publication-title: Immunol Cell Biol – volume: 180 start-page: 1894 year: 1999 end-page: 1901 ident: bib0005 article-title: The changing epidemiology of meningococcal disease in the United States, 1992–1996 publication-title: J Infect Dis – volume: 15 start-page: 155 year: 2001 end-page: 169 ident: bib0085 article-title: Meningococcal vaccines publication-title: Infect Dis Clin N Am – volume: 4 start-page: e1000107 year: 2008 ident: bib0140 article-title: Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan publication-title: PLoS Comput Biol – volume: 87 start-page: 1115 year: 1991 end-page: 1120 ident: bib0115 article-title: Bacterial meningitis: T cell activation and immunoregulatory CD4+ T cell subset alteration publication-title: J Allergy Clin Immunol – reference: The immune epitope database 2.0. Nucleic Acids Res 2010;38(Database issue):D854–62. – volume: 24 start-page: 667 year: 2003 end-page: 674 ident: bib0235 article-title: Towards in silico prediction of immunogenic epitopes publication-title: Trends Immunol – volume: 7 start-page: 153 year: 2006 ident: bib0150 article-title: Predicting population coverage of T-cell epitope-based diagnostics and vaccines publication-title: BMC Bioinform – volume: 322 start-page: 355 year: 1983 end-page: 357 ident: bib0050 article-title: Antigenic similarities between brain components and bacteria causing meningitidis. Implications for vaccine development and pathogenesis publication-title: Lancet – volume: 21 start-page: 419 year: 2003 end-page: 430 ident: bib0190 article-title: Memory T cells and vaccines publication-title: Vaccine – volume: 126 start-page: 51 year: 1972 end-page: 52 ident: bib0035 article-title: Immunologic response of man to group B meningococcal polysaccharide vaccines publication-title: J Infect Dis – volume: 10 start-page: 159 year: 1992 end-page: 163 ident: bib0135 article-title: Murine cross-reactive T-cell epitopes of publication-title: Vaccine – volume: 138 start-page: 4402 year: 1987 end-page: 4407 ident: bib0030 article-title: An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues publication-title: J Immunol – volume: 47 start-page: 135 year: 2001 end-page: 149 ident: bib0105 article-title: Novel vaccine strategies to T-independent antigens publication-title: J Microb Methods – volume: 13 start-page: 776 year: 2008 end-page: 786 ident: bib0225 article-title: Viral peptide immunogens: current challenges and opportunities publication-title: J Peptide Sci – volume: 15 start-page: 197 year: 1993 end-page: 205 ident: bib0075 article-title: A new variant of serosubtype P1.16 in publication-title: Microb Pathog – volume: 167 start-page: 1065 year: 1993 end-page: 1073 ident: bib0080 article-title: The 5C protein of publication-title: J Infect Dis – volume: 63 start-page: 836 year: 1979 end-page: 848 ident: bib0040 article-title: Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man publication-title: J Clin Invest – volume: 24 start-page: 5277 year: 2006 end-page: 5293 ident: bib0120 article-title: Proteomic analysis of publication-title: Vaccine – volume: 338 start-page: 1093 year: 1991 end-page: 1096 ident: bib0055 article-title: Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway publication-title: Lancet – volume: 50 start-page: 213 year: 1999 end-page: 219 ident: bib0170 article-title: SYFPEITHI: database for MHC ligands and peptide motifs publication-title: Immunogenetics – volume: 2 start-page: 245 year: 1994 end-page: 251 ident: bib0205 article-title: Antigen peptide binding by class I and class II histocompatibility proteins publication-title: Structure – volume: 24 start-page: 6555 year: 2006 end-page: 6563 ident: bib0130 article-title: A conjugate vaccine composed of a heat shock protein 60 T-cell epitope peptide (p458) and publication-title: Vaccine – volume: 72 start-page: 120 year: 2008 end-page: 130 ident: bib0155 article-title: Genetic affinities of north and northeastern populations of India: inference from HLA-based study publication-title: Tissue Antigens – volume: 92 start-page: 909 year: 2007 end-page: 915 ident: bib0010 article-title: Meningococcal A, C, Y and W-135 polysaccharide–protein conjugate vaccines publication-title: Arch Dis Child – volume: 2 start-page: 5134 year: 1989 end-page: 5138 ident: bib0045 article-title: Vaccines for prevention of meningococcal disease publication-title: Clin Microbial Rev – volume: 23 start-page: 2121 year: 2005 end-page: 2131 ident: bib0255 article-title: Developing an epitope-driven tuberculosis (TB) vaccine publication-title: Vaccine – volume: 4 start-page: 407 year: 2005 end-page: 417 ident: bib0180 article-title: Information technologies for vaccine research publication-title: Expert Rev Vaccines – volume: 56 start-page: 417 year: 2003 end-page: 422 ident: bib0020 article-title: The immunopathogenesis of meningococcal disease publication-title: J Clin Pathol – volume: 3 start-page: 261 year: 1987 end-page: 267 ident: bib0070 article-title: Protective efficacy of monoclonal antibodies to class 1 and class 3 outer membrane proteins of publication-title: Microb Pathog – volume: 23 start-page: 1265 year: 2005 end-page: 1272 ident: bib0260 article-title: Defining putative T cell epitopes from PE and PPE families of proteins of publication-title: Vaccine – volume: 9 start-page: S22 year: 2008 ident: bib0280 article-title: Evaluation of MHC-II peptide binding prediction servers publication-title: BMC Bioinform – volume: 331 start-page: 623 year: 2003 end-page: 641 ident: bib0195 article-title: Sequence variability analysis of human class I and class II MHC molecules: functional and structural correlates of amino acid polymorphisms publication-title: J Mol Biol – reference: A database of MHC/TAP binding peptides and T-cell epitopes. BMC Res Notes 2009;2:61. – volume: 9 start-page: 745 year: 2009 ident: 10.1016/j.vaccine.2010.08.005_bib0200 article-title: MHC superfamily structure and the immune system publication-title: Curr Opin Struct Biol doi: 10.1016/S0959-440X(99)00039-1 – volume: 11 start-page: 203 year: 2006 ident: 10.1016/j.vaccine.2010.08.005_bib0175 article-title: Immunomics: discovering new targets for vaccines and therapeutics publication-title: Drug Discov Today doi: 10.1016/S1359-6446(05)03720-7 – volume: 2 start-page: 5134 year: 1989 ident: 10.1016/j.vaccine.2010.08.005_bib0045 article-title: Vaccines for prevention of meningococcal disease publication-title: Clin Microbial Rev doi: 10.1128/CMR.2.Suppl.S134 – volume: 72 start-page: 120 issue: 2 year: 2008 ident: 10.1016/j.vaccine.2010.08.005_bib0155 article-title: Genetic affinities of north and northeastern populations of India: inference from HLA-based study publication-title: Tissue Antigens doi: 10.1111/j.1399-0039.2008.01083.x – volume: 25 start-page: 856 year: 2007 ident: 10.1016/j.vaccine.2010.08.005_bib0275 article-title: Identifying candidate subunit vaccines using an alignment-independent method based on principal amino acid properties publication-title: Vaccine doi: 10.1016/j.vaccine.2006.09.032 – volume: 87 start-page: 1115 year: 1991 ident: 10.1016/j.vaccine.2010.08.005_bib0115 article-title: Bacterial meningitis: T cell activation and immunoregulatory CD4+ T cell subset alteration publication-title: J Allergy Clin Immunol doi: 10.1016/0091-6749(91)92157-V – volume: 56 start-page: 417 year: 2003 ident: 10.1016/j.vaccine.2010.08.005_bib0020 article-title: The immunopathogenesis of meningococcal disease publication-title: J Clin Pathol doi: 10.1136/jcp.56.6.417 – volume: 57 start-page: 34 year: 1993 ident: 10.1016/j.vaccine.2010.08.005_bib0060 article-title: Meningococcal lipopolysaccharides: virulence factor and potential vaccine component publication-title: Microbiol Rev doi: 10.1128/MMBR.57.1.34-49.1993 – volume: 5 start-page: 417 year: 2004 ident: 10.1016/j.vaccine.2010.08.005_bib0215 article-title: Variation in vaccine response in normal populations publication-title: Pharmacogenomics doi: 10.1517/14622416.5.4.417 – volume: 331 start-page: 623 year: 2003 ident: 10.1016/j.vaccine.2010.08.005_bib0195 article-title: Sequence variability analysis of human class I and class II MHC molecules: functional and structural correlates of amino acid polymorphisms publication-title: J Mol Biol doi: 10.1016/S0022-2836(03)00750-2 – volume: 13 start-page: 1501 year: 1995 ident: 10.1016/j.vaccine.2010.08.005_bib0025 article-title: The antibody response to a prototype liposome vaccine containing Neisseria meningitides outer membrane protein P1 produced in Bacillus subtilis publication-title: Vaccine doi: 10.1016/0264-410X(95)00101-6 – volume: 34 start-page: 444 year: 2004 ident: 10.1016/j.vaccine.2010.08.005_bib0240 article-title: Quantitative structure-activity relationships and the prediction of MHC supermotifs publication-title: Methods doi: 10.1016/j.ymeth.2004.06.007 – volume: 131 start-page: 317 year: 2009 ident: 10.1016/j.vaccine.2010.08.005_bib0110 article-title: Evidence for dendritic cell-dependent CD4+ T helper-1 type responses to commensal bacteria in normal human intestinal laminapropria publication-title: Clin Immunol doi: 10.1016/j.clim.2008.12.003 – volume: 10 start-page: 159 year: 1992 ident: 10.1016/j.vaccine.2010.08.005_bib0135 article-title: Murine cross-reactive T-cell epitopes of Neisseria meningitidis outer membrane proteins publication-title: Vaccine doi: 10.1016/0264-410X(92)90005-5 – volume: 23 start-page: 2121 year: 2005 ident: 10.1016/j.vaccine.2010.08.005_bib0255 article-title: Developing an epitope-driven tuberculosis (TB) vaccine publication-title: Vaccine doi: 10.1016/j.vaccine.2005.01.059 – volume: 2 start-page: 245 year: 1994 ident: 10.1016/j.vaccine.2010.08.005_bib0205 article-title: Antigen peptide binding by class I and class II histocompatibility proteins publication-title: Structure doi: 10.1016/S0969-2126(00)00026-5 – volume: 13 start-page: 776 year: 2008 ident: 10.1016/j.vaccine.2010.08.005_bib0225 article-title: Viral peptide immunogens: current challenges and opportunities publication-title: J Peptide Sci doi: 10.1002/psc.896 – volume: 4 start-page: 407 year: 2005 ident: 10.1016/j.vaccine.2010.08.005_bib0180 article-title: Information technologies for vaccine research publication-title: Expert Rev Vaccines doi: 10.1586/14760584.4.3.407 – volume: 5 start-page: 597 year: 2004 ident: 10.1016/j.vaccine.2010.08.005_bib0210 article-title: The changing field of vaccine development in the genomics era publication-title: Pharmacogenomics doi: 10.1517/14622416.5.6.597 – volume: 50 start-page: 201 year: 1999 ident: 10.1016/j.vaccine.2010.08.005_bib0220 article-title: Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism publication-title: Immunogenetics doi: 10.1007/s002510050594 – volume: 3 start-page: 261 year: 1987 ident: 10.1016/j.vaccine.2010.08.005_bib0070 article-title: Protective efficacy of monoclonal antibodies to class 1 and class 3 outer membrane proteins of Neisseria meningitidis B:15:P1.16 in infant rat infection model: new prospects for vaccine development publication-title: Microb Pathog doi: 10.1016/0882-4010(87)90059-3 – volume: 37 start-page: 1094 year: 2000 ident: 10.1016/j.vaccine.2010.08.005_bib0095 article-title: Auto-transporter A (AutA) protein of Neisseria meningitidis: a potent CD4+ T-cell and B-cell stimulating antigen detected by expression cloning publication-title: Mol Microbiol doi: 10.1046/j.1365-2958.2000.02061.x – volume: 47 start-page: 135 year: 2001 ident: 10.1016/j.vaccine.2010.08.005_bib0105 article-title: Novel vaccine strategies to T-independent antigens publication-title: J Microb Methods doi: 10.1016/S0167-7012(01)00290-1 – volume: 24 start-page: 5277 year: 2006 ident: 10.1016/j.vaccine.2010.08.005_bib0120 article-title: Proteomic analysis of Neisseria lactamica and Neisseria meningitidis outer membrane vesicle vaccine antigens publication-title: Vaccine doi: 10.1016/j.vaccine.2006.03.013 – volume: 63 start-page: 836 year: 1979 ident: 10.1016/j.vaccine.2010.08.005_bib0040 article-title: Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man publication-title: J Clin Invest doi: 10.1172/JCI109383 – volume: 20 start-page: S24 year: 2001 ident: 10.1016/j.vaccine.2010.08.005_bib0065 article-title: Alternative vaccine strategies to prevent serogroup B meningococcal diseases publication-title: Vaccine doi: 10.1016/S0264-410X(01)00283-3 – volume: 338 start-page: 1093 year: 1991 ident: 10.1016/j.vaccine.2010.08.005_bib0055 article-title: Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway publication-title: Lancet doi: 10.1016/0140-6736(91)91961-S – volume: 4 start-page: e1000107 issue: 7 year: 2008 ident: 10.1016/j.vaccine.2010.08.005_bib0140 article-title: Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan publication-title: PLoS Comput Biol doi: 10.1371/journal.pcbi.1000107 – ident: 10.1016/j.vaccine.2010.08.005_bib0165 doi: 10.1093/nar/gkp1004 – volume: 24 start-page: 667 year: 2003 ident: 10.1016/j.vaccine.2010.08.005_bib0235 article-title: Towards in silico prediction of immunogenic epitopes publication-title: Trends Immunol doi: 10.1016/j.it.2003.10.006 – volume: 22 start-page: 1992 year: 2004 ident: 10.1016/j.vaccine.2010.08.005_bib0250 article-title: The societal value of universal childhood vaccination publication-title: Vaccine doi: 10.1016/j.vaccine.2003.10.027 – volume: 167 start-page: 1065 year: 1993 ident: 10.1016/j.vaccine.2010.08.005_bib0080 article-title: The 5C protein of Neisseria meningitidis is highly immunogenic in humans and induces bactericidal antibodies publication-title: J Infect Dis doi: 10.1093/infdis/167.5.1065 – volume: 92 start-page: 909 year: 2007 ident: 10.1016/j.vaccine.2010.08.005_bib0010 article-title: Meningococcal A, C, Y and W-135 polysaccharide–protein conjugate vaccines publication-title: Arch Dis Child doi: 10.1136/adc.2006.111500 – volume: 15 start-page: 197 year: 1993 ident: 10.1016/j.vaccine.2010.08.005_bib0075 article-title: A new variant of serosubtype P1.16 in Neisseria meningitidis from Norway associated with increased resistance to bactericidal antibodies induced by a serogroup B outer membrane protein vaccine publication-title: Microb Pathog doi: 10.1006/mpat.1993.1070 – volume: 25 start-page: 2768 year: 2007 ident: 10.1016/j.vaccine.2010.08.005_bib0270 article-title: Predicted epitopes of Lig A of Leptospira interrogans by bioinformatics method: a clue further vaccine development publication-title: Vaccine doi: 10.1016/j.vaccine.2006.12.023 – volume: 23 start-page: 1265 year: 2005 ident: 10.1016/j.vaccine.2010.08.005_bib0260 article-title: Defining putative T cell epitopes from PE and PPE families of proteins of Mycobacterium tuberculosis with vaccine potential publication-title: Vaccine doi: 10.1016/j.vaccine.2004.08.046 – volume: 50 start-page: 213 year: 1999 ident: 10.1016/j.vaccine.2010.08.005_bib0170 article-title: SYFPEITHI: database for MHC ligands and peptide motifs publication-title: Immunogenetics doi: 10.1007/s002510050595 – volume: 180 start-page: 1894 year: 1999 ident: 10.1016/j.vaccine.2010.08.005_bib0005 article-title: The changing epidemiology of meningococcal disease in the United States, 1992–1996 publication-title: J Infect Dis doi: 10.1086/315158 – volume: 67 start-page: 3533 year: 1999 ident: 10.1016/j.vaccine.2010.08.005_bib0090 article-title: Identification and characterization of TspA, a major CD4+ T-cell- and B-cell-stimulating Neisseria-specific antigen publication-title: Infect Immun doi: 10.1128/IAI.67.7.3533-3541.1999 – volume: 138 start-page: 4402 year: 1987 ident: 10.1016/j.vaccine.2010.08.005_bib0030 article-title: An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues publication-title: J Immunol doi: 10.4049/jimmunol.138.12.4402 – volume: 80 start-page: 255 year: 2002 ident: 10.1016/j.vaccine.2010.08.005_bib0230 article-title: Immuno-informatics: mining genomes for vaccine components publication-title: Immunol Cell Biol doi: 10.1046/j.1440-1711.2002.01092.x – volume: 126 start-page: 51 year: 1972 ident: 10.1016/j.vaccine.2010.08.005_bib0035 article-title: Immunologic response of man to group B meningococcal polysaccharide vaccines publication-title: J Infect Dis doi: 10.1093/infdis/126.5.514 – volume: 25 start-page: 7530 year: 2007 ident: 10.1016/j.vaccine.2010.08.005_bib0265 article-title: Computational analysis of proteome of H5N1 avian influenza virus to define T cell epitopes with vaccine potential publication-title: Vaccine doi: 10.1016/j.vaccine.2007.08.044 – volume: 9 start-page: S22 issue: Suppl. 12 year: 2008 ident: 10.1016/j.vaccine.2010.08.005_bib0280 article-title: Evaluation of MHC-II peptide binding prediction servers publication-title: BMC Bioinform doi: 10.1186/1471-2105-9-S12-S22 – volume: 12 start-page: 389 year: 2007 ident: 10.1016/j.vaccine.2010.08.005_bib0245 article-title: Harnessing bioinformatics to discover new vaccines publication-title: Drug Discov Today doi: 10.1016/j.drudis.2007.03.010 – volume: 2 start-page: S134 issue: Suppl. year: 1989 ident: 10.1016/j.vaccine.2010.08.005_bib0015 article-title: Vaccines for prevention of meningococcal disease publication-title: Clin Microbiol Rev doi: 10.1128/CMR.2.Suppl.S134 – volume: 15 start-page: 155 year: 2001 ident: 10.1016/j.vaccine.2010.08.005_bib0085 article-title: Meningococcal vaccines publication-title: Infect Dis Clin N Am doi: 10.1016/S0891-5520(05)70273-7 – volume: 24 start-page: 6555 year: 2006 ident: 10.1016/j.vaccine.2010.08.005_bib0130 article-title: A conjugate vaccine composed of a heat shock protein 60 T-cell epitope peptide (p458) and Neisseria meningitidis type B capsular polysaccharide publication-title: Vaccine doi: 10.1016/j.vaccine.2006.06.019 – volume: 21 start-page: 419 year: 2003 ident: 10.1016/j.vaccine.2010.08.005_bib0190 article-title: Memory T cells and vaccines publication-title: Vaccine doi: 10.1016/S0264-410X(02)00407-3 – volume: 7 start-page: 153 year: 2006 ident: 10.1016/j.vaccine.2010.08.005_bib0150 article-title: Predicting population coverage of T-cell epitope-based diagnostics and vaccines publication-title: BMC Bioinform doi: 10.1186/1471-2105-7-153 – volume: 24 start-page: 2692 year: 2006 ident: 10.1016/j.vaccine.2010.08.005_bib0125 article-title: Very small size proteoliposomes derived from Neisseria meningitidis: an effective adjuvant for generation of CTL responses to peptide and protein antigens publication-title: Vaccine doi: 10.1016/j.vaccine.2005.08.111 – volume: 28 start-page: 120 year: 2009 ident: 10.1016/j.vaccine.2010.08.005_bib0185 article-title: In silico DNA vaccine designing against human papillomavirus (HPV) causing cervical cancer publication-title: Vaccine doi: 10.1016/j.vaccine.2009.09.095 – ident: 10.1016/j.vaccine.2010.08.005_bib0160 doi: 10.1186/1756-0500-2-61 – volume: 322 start-page: 355 year: 1983 ident: 10.1016/j.vaccine.2010.08.005_bib0050 article-title: Antigenic similarities between brain components and bacteria causing meningitidis. Implications for vaccine development and pathogenesis publication-title: Lancet doi: 10.1016/S0140-6736(83)90340-9 – volume: 70 start-page: 335 year: 2002 ident: 10.1016/j.vaccine.2010.08.005_bib0100 article-title: Neisserial Immunoglobulin A1 protease induces specific T-cell responses in humans publication-title: Infect Immun doi: 10.1128/IAI.70.1.335-344.2002 |
| SSID | ssj0005319 |
| Score | 2.1393943 |
| Snippet | Neisseria meningitidis, an exclusive human pathogen, is a major cause of mortality due to meningococcal meningitis and sepsis in many developing countries.... Abstract Neisseria meningitidis , an exclusive human pathogen, is a major cause of mortality due to meningococcal meningitis and sepsis in many developing... , an exclusive human pathogen, is a major cause of mortality due to meningococcal meningitis and sepsis in many developing countries. Three meningococcal... |
| SourceID | proquest pubmed pascalfrancis crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 7092 |
| SubjectTerms | Algorithms Allergy and Immunology Antigens, Bacterial - immunology Applied microbiology Bacterial Proteins - immunology Bacteriology Biological and medical sciences Carrier Proteins - immunology Computational Biology Databases, Protein Developing countries Epitopes, T-Lymphocyte - immunology Fundamental and applied biological sciences. Psychology Genomes HLA-DR Antigens - immunology Humans LDCs Lymphocytes Meningitis MHC polymorphism Microbiology Miscellaneous Neisseria meningitidis Neisseria meningitidis, Serogroup B - immunology Neural networks Neural Networks (Computer) Peptides Population Population coverage Proteins Serine Endopeptidases - immunology Servers T-cell epitope Vaccine Vaccines Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) |
| SummonAdditionalLinks | – databaseName: Elsevier SD Freedom Collection Journals [SCFCJ] dbid: AIKHN link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwELdGJxASQlD-BcZ0SGgvLGv-2E76WApTB6yaRIf6ZiWOI2UqabS0SHvjQ_Ah-Fx8Es6O02iCagipT44vcezz3c_N7-4Iec25kknCmBuoUOkSZtyNeRbpo0ooZR7SgOrg5NMpn5zTD3M23yHjNhZG0yqt7W9surHWtmVgZ3NQFcXgs2d8uTf3Tb10Or9FdtH_xHGP7I5OPk6mHdMjNPU9dH9XC3SBPIOLo2-J1F-wLclLEyvZNhd1r0pqnLi8qXixHZIa13T8gNy3mBJGzbAfkh1V9sntpsrkVZ_cObXfz_vk4KzJVH11CLMu8Ko-hAM463JYo0z_i6bJmFhdaMUfkZ8nJdTFApUHxu_oG5i5-n9_UBWahUpBdal76pWGpMxg8mkEmc7La0tqYWOTAAUQKAMCT6iWK01WwrGbdBFFWcMyh6kyHIEiga-qqadU4G0ArdrSxKDA21_ff4xALtbK3MnOLWQd_-kxOT9-PxtPXFvqwZWM05WbSl__mPRSxK8mWhZxmT-MfJXkw5DLSMZ5lsokDqlSuV55bMy9lHIPL7PwCemVy1I9I-CnnA0zhCY5w6NnkKeBlye5SlSsshjxsENou7pC2jzouhzHQrSEtwthBy60UghdptNjDjnaiFVNIpCbBHirOqKNckW7LNBV3SQY_U1Q1da61MIXdSA88ccOcEi8kby2if7lofvXtHvzjkGIOIdGnkP2WnUX3UBwcyN-5zx2yKvNZTRQWvuSUi3X2IfplFEBLpNDYEufiEWUh1HsO-Rps5O653v6RE_j5___bi_IXcP5MMzNPdJbXa7VS4SSq3TfmorfvkF0xg priority: 102 providerName: Elsevier |
| Title | In silico CD4+ T-cell epitope prediction and HLA distribution analysis for the potential proteins of Neisseria meningitidis Serogroup B—A clue for vaccine development |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0264410X1001114X https://www.clinicalkey.es/playcontent/1-s2.0-S0264410X1001114X https://dx.doi.org/10.1016/j.vaccine.2010.08.005 https://www.ncbi.nlm.nih.gov/pubmed/20716448 https://www.proquest.com/docview/1497226668 https://www.proquest.com/docview/1500772093 https://www.proquest.com/docview/757463781 |
| Volume | 28 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals [SCFCJ] customDbUrl: eissn: 1873-2518 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0005319 issn: 0264-410X databaseCode: AIKHN dateStart: 20091030 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Science Direct customDbUrl: eissn: 1873-2518 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0005319 issn: 0264-410X databaseCode: .~1 dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: ScienceDirect customDbUrl: eissn: 1873-2518 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0005319 issn: 0264-410X databaseCode: ACRLP dateStart: 20091030 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 1873-2518 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0005319 issn: 0264-410X databaseCode: AKRWK dateStart: 19831201 isFulltext: true providerName: Library Specific Holdings – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1873-2518 dateEnd: 20250901 omitProxy: true ssIdentifier: ssj0005319 issn: 0264-410X databaseCode: BENPR dateStart: 20020101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Health & Medical customDbUrl: eissn: 1873-2518 dateEnd: 20250901 omitProxy: true ssIdentifier: ssj0005319 issn: 0264-410X databaseCode: 7X7 dateStart: 20020101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1873-2518 dateEnd: 20250901 omitProxy: true ssIdentifier: ssj0005319 issn: 0264-410X databaseCode: 8C1 dateStart: 20020101 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1tb9MwELa2ViAkhKC8BUZ1SGhfWLq82E76AaGubOqAVRVsU75ZieNInUoalhZpX_g7_E3OTtIIiTKkKIoSn-3Gl_Pj-u4eQt5wrmQcM2Z7yleawozbIU8DvVTxpcx86lEdnHw25ZML-jFi0Q6ZNrEw2q2ysYnGUKdLqf8jP0QkHyBU4Dx8X3y3NWuU3l1tKDTimlohfWdSjO2SrqczY3VI9-h4OvvSOn34huoDFx7Upq4TtTE9h1eDH1gLQrva30v7WLJts9X9Ii7xHWYV-cV2dGpmqZOH5EENL2FU6cMjsqPyHrlTEU7e9Mjds3orvUf2Z1XS6psDOG9jsMoD2IdZm84aZXqX2mPGhO1CI_6Y_DrNoZwvUI9g_IG-hXNbbwGAKtBCFAqKa11SDzrEeQqTzyNIdYreml0Lb1a5UAAxMyAGhWK50n5L2HeTOWKel7DMYKqMu8A8hm-qolaaYzWABm5pwlHgyLZHIBdrZSqqXy2krSfUE3Jxcnw-ntg16YMtGacrO5GuPph0EkSyJm4WEZo7DFwVZ0Ofy0CGWZrIOPSpUpnGc3gzcxLKHXzM_Kekky9z9ZyAm3A2TBGkZAwXoV6WeE4WZypWoUpDRMYWoc3gCllnRNfEHAvRuL5dibrjQuuE0ISdDrPIYCNWVClBbhPgjeaIJt4VLbTASes2weBvgqqs7UwpXFF6whFfHYNrnUhn1MIVbmSRcCNZQ6kKIv1Po_0_lHvzGz0fEQ8NHIvsNdou2o5sPk-LvN48RlOllS_O1XKNZZhOHuXhMFkEtpQJWEC5H4SuRZ5VH1LbvqPX9jR88e_2X5J7xsPD-Gnukc7qeq1eIXBcJX2yO_jp4jmIAjyHY7zujk4_Tab92k78Bqe5cnA |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLamTVwkhKDcAmMcJNgLy5aL46QPE-puallbVdChvplcHKlTScLSgvqL-Bf8No4dpxESZbxM6lPiE7v16fHn-DvnI-QNYyIOQ88zHeEKKWHGzIAlvtyquHGcutShMjl5MGTdC_ph4k02yK86F0bSKuuYqAJ1ksfyHfkBInkfoQJjwfvimylVo-Tpai2hEWppheRQlRjTiR3nYvkDt3DlYe8E5_ut45ydjo-7plYZMGOP0bkZxbb8eLEVIXRSiZoICey2b4swbbss9uMgTaI4DFwqRCoBBF5MrYgyC29L1QhcAraoiwPcJFtHp8PRx4Zk4ippEdzoUJPa1qTJITq43P-Oo0YoqfllktPprVsd7xVhiXOWVmIb69GwWhXPHpD7Gs5Cp_K_h2RDZC1yqxK4XLbI7YE-um-R3VFVJHu5B-Mm56vcg10YNeWz0ab1WTJ0VJow1OaPyM9eBuV0hn4Lxyf0HYxNeeQAosCIVAgormRL6WQQZgl0-x1IZElgreaFF6vaK4AYHRDzQpHPJU8Kx64qVUyzEvIUhkLRE6YhfBWVlNMUHwMYUHOV_gJHptmBeLYQ6kH6p4WkYV49Jhc3Mv1PyGaWZ-IZATtiXjtBUJR6uOl10six0jAVoQhEEiASNwitJ5fHugK7FAKZ8Zpqd8n1wLn0CS4FQi3PIPsrs6IqQXKdAas9h9f5tbgicFwkrzP0_2YoSh3XSm7z0uEW_2QpHG1NZAUv3FFPDBKsLDV0qyDZ_3S684dzr76j4yLCor5lkO3a23kzkFU4MMjr1W0MjdL5wkzkC2zjyWJVDk6TQWBNG9_zKXP9wDbI0-qP1PRvyXcJNHj-7_5fkTvd8aDP-73h-QtyV7FLFEd0m2zOrxbiJYLWebSjIwOQLzcdjH4DHSOqeg |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtQwELWqIiokhGC5BUoZJOgLTTcXx8k-IFRaVi1tV5Voq7yZxHGkrZYkNFtQv4h_4OuYcZKNkCjlpdI-JZ7Yu54dH8dn5jD2WgitkiQIbE_7miTMhB2JLKStiq9U7nOPU3Ly4UTsnvBPcRAvsV9dLgzRKruYaAJ1Vip6Rz5EJB8iVBAiGuYtLeJoZ_y--maTghSdtHZyGo2L7OvLH7h9q9_t7eBcv_G88cfj7V27VRiwVSD43E6VS59AOSnCJpOkiXDAHYWuTvKRL1SoojxLVRL5XOucwANezJ2UCwdvk2IEhv9boe-PiE4YxmFPL_GNqAhucbjNXSfus4eGZ5vfE0XH5i2zjNicwVXr4t0qqXG28kZm42ocbNbD8X12rwWysNV43gO2pIsBu91IW14O2Mphe2g_YOtHTXnsyw047rO96g1Yh6O-cDbaDE6Jm2MShKEzf8h-7hVQT2fosbC9w9_CsU2HDaArjEWVhuqcWpJ7QVJksHuwBRkVA251vPBiU3UFEJ0Dol2oyjkxpHDspkbFtKihzGGiDTFhmsBX3Yg4TfExgKG0NIkv8MG2t0DNLrR5UPvTQtZzrh6xkxuZ_MdsuSgL_ZSBm4pglCEcygPc7np56jl5kutERzqLEINbjHeTK1Vbe50kQGayI9mdyXbgknxCkjSoE1hsc2FWNcVHrjMQnefILrMW1wKJy-N1huHfDHXdRrRaurL2pCM_OwZBOzHV7sK9dGyxaGHZgrYGjP1Pp2t_OPfiO3o-YiseOhZb7bxd9gNZBAKLvVrcxqBIzpcUurzANgGVqfJwmiwGV7QJg5ALP4xciz1p_kh9_w69ReDRs3_3_5KtYAiSB3uT_efsjqGVGHLoKluen1_oF4hW5-maCQvAvtx0HPoNcq2oFA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+silico+CD4%2B+T-cell+epitope+prediction+and+HLA+distribution+analysis+for+the+potential+proteins+of+Neisseria+meningitidis+Serogroup+B--A+clue+for+vaccine+development&rft.jtitle=Vaccine&rft.au=Gupta%2C+Shishir+K&rft.au=Smita%2C+Suchi&rft.au=Sarangi%2C+Aditya+Narayan&rft.au=Srivastava%2C+Mugdha&rft.date=2010-10-08&rft.pub=Elsevier+Limited&rft.issn=0264-410X&rft.eissn=1873-2518&rft.volume=28&rft.issue=43&rft.spage=7092&rft_id=info:doi/10.1016%2Fj.vaccine.2010.08.005&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=3216315331 |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F0264410X%2FS0264410X10X00469%2Fcov150h.gif |